STAAR Surgical Company (FRA:SR3)
Germany flag Germany · Delayed Price · Currency is EUR
22.71
+0.21 (0.93%)
At close: Dec 5, 2025

STAAR Surgical Company Company Description

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.

The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.

It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists.

The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally.

STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAAR Surgical Company
Country United States
Founded 1982
Industry Ophthalmic Goods
Employees 1,157
CEO Stephen Farrell

Contact Details

Address:
25510 Commercentre Drive
Lake Forest, Delaware 92630
United States
Phone 626 303 7902
Website staar.com

Stock Details

Ticker Symbol SR3
Exchange Frankfurt Stock Exchange
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
SIC Code 3851

Key Executives

Name Position
Stephen Farrell Chief Executive Officer
Deborah Andrews Chief Financial Officer
Warren Foust Chief Operating Officer